【24h】

Sample pooling to enhance throughput of brain penetration study.

机译:样品池可提高大脑渗透研究的通量。

获取原文
获取原文并翻译 | 示例
           

摘要

The advent of combinatorial synthesis and high throughput screening in pharmaceutical research has inevitably given rise to a large number of interesting prelead compounds that requires rapid analytical throughput for kinetic characterization. The traditional approach of one-compound-at-a-time bioanalysis has not been able to meet the demand for high productivity of pharmacokinetic screening. This report demonstrates the application of sample pooling in expediting the pharmacokinetic screening, including assessment of brain penetration, of six NK1 receptor antagonists in rats: CAM 6108 (C1), CAM 6122 (C2), CAM 6178 (C3), CAM 5825 (C4), CAM 6182 (C5), and CAM 6121 (C6). The approach was adopted to avoid complications associated with cocktail dosing where multiple compounds are administered to one animal. The present investigation features individualized dosing (one compound per animal), followed by sample pooling of brain and plasma and bioanalysis via a conventional LC-fluorescence method. Rats were dosed intravenously with each of the six NK1 receptor antagonists and blood and brain samples were harvested at suitable post-dose time intervals. Plasma or brain homogenate samples from the same time points were pooled into two groups (C1-C3 and C4-C6) for assay. Drug compounds in plasma or brain were extracted by protein precipitation and quantitated using a validated gradient HPLC/fluorescence method, which was made feasible for both groups of compounds with a modification in gradient scheme. Plasma assay precision and accuracy for C1-C6 were < or =4.7% and within +/-9.8%, respectively. Brain homogenate assay accuracy for C1-C6 was within +/-7.0%. Brain penetration of these compounds was evaluated as the AUC of brain and plasma and their respective brain/plasma AUC ratio. The sample pooling approach helped to quickly identify C1 as the NK1 receptor antagonist with the greatest extent of brain penetration, followed by C2, C6, C4, C5, and C3 in that order. By employing sample pooling approach, pharmacokinetic parameters and brain penetration of all six compounds were obtained in a fraction of the time required by conventional single compound dosing and analysis.
机译:药物研究中组合合成和高通量筛选的出现不可避免地产生了许多有趣的前导化合物,这些化合物需要快速的分析通量来进行动力学表征。一次一次化合物生物分析的传统方法无法满足对药代动力学筛选高生产率的需求。该报告证明了样品池在加快大鼠六种NK1受体拮抗剂药代动力学筛选(包括评估脑渗透性)中的应用:CAM 6108(C1),CAM 6122(C2),CAM 6178(C3),CAM 5825(C4 ),CAM 6182(C5)和CAM 6121(C6)。采用该方法是为了避免对一只动物施用多种化合物而引起的鸡尾酒混合的并发症。本研究的特点是个体化给药(每只动物一种化合物),然后通过常规LC荧光方法对大脑和血浆进行样品合并以及生物分析。给大鼠静脉内给予六种NK1受体拮抗剂,并在适当的给药后时间间隔内采集血液和脑样本。将来自相同时间点的血浆或脑匀浆样品合并为两组(C1-C3和C4-C6)进行分析。血浆或脑中的药物化合物通过蛋白质沉淀法提取,并使用经过验证的梯度HPLC /荧光法进行定量,这对于两组经过梯度方案修改的化合物均可行。 C1-C6的血浆测定精度和准确度分别为<或= 4.7%和+/- 9.8%以内。 C1-C6的脑匀浆测定准确性在+/- 7.0%以内。将这些化合物的脑渗透率评估为脑和血浆的AUC及其各自的脑/血浆AUC比。样本汇总方法有助于快速将C1识别为具有最大程度的脑部渗透的NK1受体拮抗剂,其后依次是C2,C6,C4,C5和C3。通过采用样品合并方法,可以在传统单一化合物定量和分析所需时间的一小部分内获得所有六种化合物的药代动力学参数和脑渗透性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号